Exchange: OTC·Updated 03:40 PM EDT

MDNAFMedicenna Therapeutics Corp

$0.256
$0.001
(0.39%)
Today
Reported EarningsJun 25
Mkt Cap$19.87M
Vol98,459.00
News
all
press releases
News Placeholder
Medicenna Therapeutics (MDNAF) Upgraded to Buy: Here's What You Should Know
Medicenna Therapeutics (MDNAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
<
...
1
>
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.